GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM Tags GLP-1 agonists MASLD/MASH SGLT-2 Inhibitor Thiazolidinediones Read more about GLP-1RAs and SGLT2 Inhibitors Showed Favorable Liver Outcomes in T2DM
Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis Tags ASCVD Coronary artery disease GLP-1 agonists Myocardial infarction Read more about Combined BP and Diabetes Therapy Improved CV Outcomes in Meta-analysis
GIP Infusion Did Not Improve Glycemic Control in Type 2 Diabetes Tags GLP-1 agonists Read more about GIP Infusion Did Not Improve Glycemic Control in Type 2 Diabetes
Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i Tags DPP-4 inhibitors GLP-1 agonists SGLT-2 Inhibitor Read more about Safety Profiles Differed Across SGLT2i, GLP-1 RA, and DPP-4i
Semaglutide Improved Insulin Sensitivity in Adolescents With Obesity Tags GLP-1 agonists Read more about Semaglutide Improved Insulin Sensitivity in Adolescents With Obesity
Semaglutide Shows Reassuring Safety Signal After Dialysis Initiation Tags GLP-1 agonists Read more about Semaglutide Shows Reassuring Safety Signal After Dialysis Initiation
GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM Tags Biguanide Continuous glucose monitoring (CGM) DPP-4 inhibitors GLP-1 agonists Hypoglycemia Long acting Sulphonylureas hBA1c Read more about GRADE CGM Analysis Favors Incretin Therapy Over Glimepiride in T2DM
Meta-analysis Links GLP-1 RAs to Increased Hair Loss Risk Tags GLP-1 agonists Read more about Meta-analysis Links GLP-1 RAs to Increased Hair Loss Risk
Review Shows Mixed Findings on GLP-1 RAs and Suicidal Behaviors Tags GLP-1 agonists Read more about Review Shows Mixed Findings on GLP-1 RAs and Suicidal Behaviors
GLP-1 RA Use Not Associated With Increased Safety Risks in OUD Tags GLP-1 agonists Read more about GLP-1 RA Use Not Associated With Increased Safety Risks in OUD